Don't let D-dimer fool you: Elevated D-dimer plasma levels should not imply ‘hyperfibrinolysis’-Reference-Cited by-同舟云学术

Don't let D-dimer fool you: Elevated D-dimer plasma levels should not imply ‘hyperfibrinolysis’

Published:2022-06 Issue: Volume:214 Page:63-64
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Hardy M.,Bareille M.,Lecompte T.,Mullier F.

Publisher

Elsevier BV

Subject

Hematology

Reference16 articles.

1. Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19?;Nielsen;Thromb. Res.,2021

2. Review of D-dimer testing: good, bad, and ugly;Linkins;Int. J. Lab. Hematol.,2017

3. The fibrinolytic system and the regulation of lung epithelial cell proteolysis, signaling, and cellular viability;Shetty;Am. J. Phys. Lung Cell. Mol. Phys.,2008

4. All those D-dimers in COVID-19;Thachil;J. Thromb. Haemost.,2020

5. Histopathological observations in COVID-19: a systematic review;Deshmukh;J. Clin. Pathol.,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Temporal changes in markers of coagulation and fibrinolysis in adults during extracorporeal membrane oxygenation;Perfusion;2024-07-25

2. Coagulation Disorders in Sepsis and COVID-19—Two Sides of the Same Coin? A Review of Inflammation–Coagulation Crosstalk in Bacterial Sepsis and COVID-19;Journal of Clinical Medicine;2023-01-11

3. D-dimer testing: A narrative review;Advances in Clinical Chemistry;2023

4. Predictive ability of viscoelastic testing using ClotPro® for short-term outcome in patients with severe Covid-19 ARDS with or without ECMO therapy: a retrospective study;Thrombosis Journal;2022-08-29